Stock Price
1,187.65
Daily Change
5.15 0.44%
Monthly
-3.86%
Yearly
-0.34%
Q1 Forecast
1,189.51

Aurobindo Pharma reported INR350.34B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Cipla INR 329.19B 16.3B Sep/2025
Divis Laboratories Ltd INR 154.13B 4.44B Sep/2025
Dr.Reddys Laboratories INR 375.76B 13.67B Dec/2025
Hindustan Unilever INR 487.16B 8.93B Sep/2025
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
UPL INR 318.94B 59.32B Sep/2025